{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "Genzyme", "item": "https://www.patentleaderboard.com/company/genzyme"}, {"@type": "ListItem", "position": 3, "name": "Michael O'Callaghan", "item": "https://www.patentleaderboard.com/inventor/fl:mi_ln:o'callaghan-4"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
MO

Michael O'Callaghan — 2 Patents

GEGenzyme: 2 patents #327 of 891Top 40%
Framingham, MA: #653 of 1,271 inventorsTop 55%
Massachusetts: #42,563 of 88,656 inventorsTop 50%
Overall (All Time): #1,709,992 of 4,157,543Top 45%
2 Patents All Time
Michael O'Callaghan has been granted 2 US patents while listed as an inventor at Genzyme. The first was granted in 2016 and the most recent in June 2019. Michael O'Callaghan ranks #1,709,992 of 4,157,543 US inventors in our database (top 41.1%). Patent records list Michael O'Callaghan in Framingham, MA, US.

Issued Patents All Time

Showing 1–2 of 2 patents

Patent #TitleCo-InventorsDate
10308917 Nucleotide sequences encoding VEGF antagonist compositions of FLT-1 and uses thereof James Stefano, Clark Pan, Huawei Qiu, Gloria Matthews 2019-06-04
9441029 VEGF antagonist compositions and uses thereof James Stefano, Clark Pan, Huawei Qiu, Gloria Matthews 2016-09-13